These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 34066934)

  • 21. [Antigenic and immunogenic activity of virus-like particles based on rabbit hemorrhagic disease virus (Caliciviridae:
    Mukhin AN; Alekseev KP; Yuzhakov AG; Selezneva EV; Moskvinа AS; Verkhovsky OA; Aliper TI
    Vopr Virusol; 2023 May; 68(2):132-141. PubMed ID: 37264848
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neutralization effects of antibody elicited by chimeric HBV S antigen viral-like particles presenting HCV neutralization epitopes.
    Wei S; Lei Y; Yang J; Wang X; Shu F; Wei X; Lin F; Li B; Cui Y; Zhang H; Wei S
    Vaccine; 2018 Apr; 36(17):2273-2281. PubMed ID: 29576303
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel chimeric foot-and-mouth disease virus-like particles harboring serotype O VP1 protect guinea pigs against challenge.
    Li H; Li Z; Xie Y; Qin X; Qi X; Sun P; Bai X; Ma Y; Zhang Z
    Vet Microbiol; 2016 Feb; 183():92-6. PubMed ID: 26790940
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunogenicity of different recombinant rabbit hemorrhagic disease virus-like particles carrying CD8+ T cell epitope from chicken ovalbumin (OVA).
    Chen M; Song Y; Fan Z; Jiang P; Hu B; Xue J; Wei H; Wang F
    Virus Res; 2014 Apr; 183():15-22. PubMed ID: 24457072
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protective immune responses against foot-and-mouth disease virus by vaccination with a DNA vaccine expressing virus-like particles.
    Jin H; Xiao W; Xiao C; Yu Y; Kang Y; Du X; Wei X; Wang B
    Viral Immunol; 2007 Sep; 20(3):429-40. PubMed ID: 17931113
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Generation and immunogenicity of porcine circovirus type 2 chimeric virus-like particles displaying porcine reproductive and respiratory syndrome virus GP5 epitope B.
    Hu G; Wang N; Yu W; Wang Z; Zou Y; Zhang Y; Wang A; Deng Z; Yang Y
    Vaccine; 2016 Apr; 34(16):1896-903. PubMed ID: 26930366
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enhanced protective immune response of foot-and-mouth disease vaccine through DNA-loaded virus-like particles.
    Lu Y; Dong H; Li J; Li L; Wang M; Liu H; Teng Z; Zhang Y; Jin Y; Guo H; Yang Y; Wen X; Sun S
    Microb Pathog; 2020 Jun; 143():104130. PubMed ID: 32165331
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatitis B virus core particles containing multiple epitopes confer protection against enterovirus 71 and coxsackievirus A16 infection in mice.
    Huo C; Yang J; Lei L; Qiao L; Xin J; Pan Z
    Vaccine; 2017 Dec; 35(52):7322-7330. PubMed ID: 29129453
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An Adenovirus Vector Expressing FMDV RNA Polymerase Combined with a Chimeric VLP Harboring a Neutralizing Epitope as a Prime Boost Strategy to Induce FMDV-Specific Humoral and Cellular Responses.
    Rangel G; Martín V; Bárcena J; Blanco E; Alejo A
    Pharmaceuticals (Basel); 2021 Jul; 14(7):. PubMed ID: 34358101
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chimeric virus-like particles for the delivery of an inserted conserved influenza A-specific CTL epitope.
    Cheong WS; Reiseger J; Turner SJ; Boyd R; Netter HJ
    Antiviral Res; 2009 Feb; 81(2):113-22. PubMed ID: 19007818
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A bivalent dendrimeric peptide bearing a T-cell epitope from foot-and-mouth disease virus protein 3A improves humoral response against classical swine fever virus.
    Bohórquez JA; Defaus S; Muñoz-González S; Perez-Simó M; Rosell R; Fraile L; Sobrino F; Andreu D; Ganges L
    Virus Res; 2017 Jun; 238():8-12. PubMed ID: 28571760
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Feasibility of Cowpea chlorotic mottle virus-like particles as scaffold for epitope presentations.
    Hassani-Mehraban A; Creutzburg S; van Heereveld L; Kormelink R
    BMC Biotechnol; 2015 Aug; 15():80. PubMed ID: 26311254
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel recombinant chimeric virus-like particle is immunogenic and protective against both enterovirus 71 and coxsackievirus A16 in mice.
    Zhao H; Li HY; Han JF; Deng YQ; Zhu SY; Li XF; Yang HQ; Li YX; Zhang Y; Qin ED; Chen R; Qin CF
    Sci Rep; 2015 Jan; 5():7878. PubMed ID: 25597595
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunogenicity and protective efficacy of recombinant proteins consisting of multiple epitopes of foot-and-mouth disease virus fused with flagellin.
    Cui B; Liu X; Zhou P; Fang Y; Zhao D; Zhang Y; Wang Y
    Appl Microbiol Biotechnol; 2019 Apr; 103(8):3367-3379. PubMed ID: 30888465
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A bivalent B-cell epitope dendrimer peptide can confer long-lasting immunity in swine against foot-and-mouth disease.
    Cañas-Arranz R; Forner M; Defaus S; Rodríguez-Pulido M; de León P; Torres E; Bustos MJ; Borrego B; Sáiz M; Blanco E; Andreu D; Sobrino F
    Transbound Emerg Dis; 2020 Jul; 67(4):1614-1622. PubMed ID: 31994334
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunization with DNA Plasmids Coding for Crimean-Congo Hemorrhagic Fever Virus Capsid and Envelope Proteins and/or Virus-Like Particles Induces Protection and Survival in Challenged Mice.
    Hinkula J; Devignot S; Åkerström S; Karlberg H; Wattrang E; Bereczky S; Mousavi-Jazi M; Risinger C; Lindegren G; Vernersson C; Paweska J; van Vuren PJ; Blixt O; Brun A; Weber F; Mirazimi A
    J Virol; 2017 May; 91(10):. PubMed ID: 28250124
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel expression of immunogenic foot-and-mouth disease virus-like particles in Nicotiana benthamiana.
    Veerapen VP; van Zyl AR; Wigdorovitz A; Rybicki EP; Meyers AE
    Virus Res; 2018 Jan; 244():213-217. PubMed ID: 29196195
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rational design of novel fusion rabies glycoproteins displaying a major antigenic site of foot-and-mouth disease virus for vaccine applications.
    Garay E; Fontana D; Leschiutta L; Kratje R; Prieto C
    Appl Microbiol Biotechnol; 2022 Jan; 106(2):579-592. PubMed ID: 34971413
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adenovirus-vectored type Asia1 foot-and-mouth disease virus (FMDV) capsid proteins as a vehicle to display a conserved, neutralising epitope of type O FMDV.
    Chai Z; Wang H; Zhou G; Yang D; Wang J; Yu L
    J Virol Methods; 2013 Mar; 188(1-2):175-82. PubMed ID: 22981982
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunizations with chimeric hepatitis B virus-like particles to induce potential anti-hepatitis C virus neutralizing antibodies.
    Vietheer PT; Boo I; Drummer HE; Netter HJ
    Antivir Ther; 2007; 12(4):477-87. PubMed ID: 17668556
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.